Delivery of Two Million Russian Vaccines to Serbia Agreed

The Russian Fund for Direct Investments and the Government of Serbia have agreed the delivery of 2 million Sputnik V vaccines against coronavirus, as announced on the official Twitter account of the vaccine.

– The Russian Fund for Direct Investments and the Government of Serbia announce the reaching of the agreement on the delivery of 2 million doses of the Sputnik V vaccine, the first registered coronavirus vaccine in the world, to the country. The vaccination of the populace against coronavirus with the Sputnik V vaccine began today in Serbia – the press release says.

The first quantities arrived to Serbia on December 30, 2020. The vaccine was approved without additional clinical tests in the country.

The agreement between the Russian Fund and the Government of Serbia will enable the vaccination of a million people (the vaccine consists of two doses).

– The deliveries of Sputnik V will enable Serbia to diversify its portfolio of vaccines against coronavirus. The vaccine for Serbia will be produced by international partners of the Russian Fund in India, China, South Korea and other countries – the press release says.

– A long-term partnership connects Russia and Serbia and we support the government’s decision to use Sputnik V in fighting coronavirus. The vaccine is based on a well-studied platform of human adenovirus vectors, which is proven to be safe – said the CEO of the fund, Kirill Dmitriev.

Sputnik V, produced by the Gamaleya Research Institute of Epidemiology and Microbiology in cooperation with the Russian Fund for Direct Investments, received a confirmation of registrations from the Ministry of Health of Russia on August 11, thereby becoming the first registered vaccine against coronavirus in the world. The vaccine is based on a tested platform of human adenovirus vectors, whose important advantages are safety, efficiency and lack of long-term adverse effects, according to the Sputnik portal.

Vlada Republike Srbije

Russian Fund for Direct Investments

Gamaleya

Ministry of Health of Russia

Sputnik V

Kirill Dmitriev

Russian vaccine

coronavirus